Nov 05, 2019 - Incyte (INCY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Nov 21, 2019 - Merck's (MRK) Keytruda gets approval in Europe to treat first-line head/neck cancer based on data from the phase III KEYNOTE-048 study.
Nov 28, 2019 - The FDA accepts and grants priority review to Incyte's (INCY) new drug application for pemigatinib as a second-line treatment for patients with FGFR2 translocated cholangiocarcinoma.
Dec 24, 2019 - Is (INCY) Outperforming Other Medical Stocks This Year?
Dec 28, 2019 - Few biotech companies ever reach that valuation, and if they do, you should snap them up for your portfolio.
Jan 03, 2020 - Novan (NASDAQ:NOVN) -73% on failed SB206 study.DPW Holdings (NYSEMKT:DPW) -30% on doubts over FINRA approval of proposed acquisitions.Landec (NASDAQ:LNDC) -15% on Q2 earnings.Mereo BioPharma Group (NA
Jan 03, 2020 - BMO Capital Markets issues rating change for INCY
Jan 06, 2020 - Companies In The News Are: CANF, LW, INCY, NOVN
Jan 08, 2020 - A low-key week for the biotech sector, with a few pipeline and regulatory updates.
Nov 19, 2019 - We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.